Current and Future Therapies for Alzheimer Disease

Paramita Chakrabarty, Pritam Das, Todd E. Golde

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)
Original languageEnglish (US)
Title of host publicationProtein Misfolding Diseases: Current and Emerging Principles and Therapies
PublisherJohn Wiley and Sons
Pages711-774
Number of pages64
ISBN (Print)9780471799283
DOIs
StatePublished - Jul 2 2010

Fingerprint

Alzheimer Disease
Therapeutics

Keywords

  • Alzheimer disease - current and future therapies
  • APP AND Aβ-specific therapeutic targets - Aβ production by β- and g-secretase cleavage of APP, one of the most pivotal points for therapeutic intervention in AD
  • TAU-specific therapeutic targets - hyperphosphorylated TAU as paired helical filaments (PHFs)
  • Within neurofibrillary tangles (NFTs)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Chakrabarty, P., Das, P., & Golde, T. E. (2010). Current and Future Therapies for Alzheimer Disease. In Protein Misfolding Diseases: Current and Emerging Principles and Therapies (pp. 711-774). John Wiley and Sons. https://doi.org/10.1002/9780470572702.ch34

Current and Future Therapies for Alzheimer Disease. / Chakrabarty, Paramita; Das, Pritam; Golde, Todd E.

Protein Misfolding Diseases: Current and Emerging Principles and Therapies. John Wiley and Sons, 2010. p. 711-774.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chakrabarty, P, Das, P & Golde, TE 2010, Current and Future Therapies for Alzheimer Disease. in Protein Misfolding Diseases: Current and Emerging Principles and Therapies. John Wiley and Sons, pp. 711-774. https://doi.org/10.1002/9780470572702.ch34
Chakrabarty P, Das P, Golde TE. Current and Future Therapies for Alzheimer Disease. In Protein Misfolding Diseases: Current and Emerging Principles and Therapies. John Wiley and Sons. 2010. p. 711-774 https://doi.org/10.1002/9780470572702.ch34
Chakrabarty, Paramita ; Das, Pritam ; Golde, Todd E. / Current and Future Therapies for Alzheimer Disease. Protein Misfolding Diseases: Current and Emerging Principles and Therapies. John Wiley and Sons, 2010. pp. 711-774
@inbook{ff396daeaf974463b38812219f641201,
title = "Current and Future Therapies for Alzheimer Disease",
keywords = "Alzheimer disease - current and future therapies, APP AND Aβ-specific therapeutic targets - Aβ production by β- and g-secretase cleavage of APP, one of the most pivotal points for therapeutic intervention in AD, TAU-specific therapeutic targets - hyperphosphorylated TAU as paired helical filaments (PHFs), Within neurofibrillary tangles (NFTs)",
author = "Paramita Chakrabarty and Pritam Das and Golde, {Todd E.}",
year = "2010",
month = "7",
day = "2",
doi = "10.1002/9780470572702.ch34",
language = "English (US)",
isbn = "9780471799283",
pages = "711--774",
booktitle = "Protein Misfolding Diseases: Current and Emerging Principles and Therapies",
publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Current and Future Therapies for Alzheimer Disease

AU - Chakrabarty, Paramita

AU - Das, Pritam

AU - Golde, Todd E.

PY - 2010/7/2

Y1 - 2010/7/2

KW - Alzheimer disease - current and future therapies

KW - APP AND Aβ-specific therapeutic targets - Aβ production by β- and g-secretase cleavage of APP, one of the most pivotal points for therapeutic intervention in AD

KW - TAU-specific therapeutic targets - hyperphosphorylated TAU as paired helical filaments (PHFs)

KW - Within neurofibrillary tangles (NFTs)

UR - http://www.scopus.com/inward/record.url?scp=84886153680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886153680&partnerID=8YFLogxK

U2 - 10.1002/9780470572702.ch34

DO - 10.1002/9780470572702.ch34

M3 - Chapter

SN - 9780471799283

SP - 711

EP - 774

BT - Protein Misfolding Diseases: Current and Emerging Principles and Therapies

PB - John Wiley and Sons

ER -